According to our (Global Info Research) latest study, the global Phacoemulsification-Vitrectomy System market size was valued at US$ 282 million in 2025 and is forecast to a readjusted size of US$ 449 million by 2032 with a CAGR of 6.9% during review period.
In 2025, global Phacoemulsification-Vitrectomy System production reached approximately 1,681 units, with an average global market price of around 163 K USD per unit. Phacoemulsification-vitrectomy (phaco-vitrectomy) system is an ophthalmic surgical device. Combined phacoemulsification-vitrectomy is a useful procedure in patients with a range of vitreoretinal disorders concomitant with visually significant cataract. The combined, or simultaneous, procedure can be used as an alternative to sequential lens and vitreous surgeries.
The global market for Phacoemulsification-Vitrectomy Systems is currently dominated by a few international giants, exhibiting a highly concentrated landscape. As a core piece of equipment in ophthalmic surgery, this system faces extremely high technological barriers, and its development is directly fueled by the global aging population and the rising incidence of ocular diseases such as cataracts and diabetic retinopathy. Presently, the Asia-Pacific region is the largest regional market, while the domestic market in China remains entirely import-dependent with no domestically produced systems yet approved, though it stands at a critical inflection point for import substitution. The development trend is clearly characterized by technological integration and intelligence, with systems continuously combining phacoemulsification and vitrectomy functions and evolving towards enhanced surgical efficiency and safety. Key growth opportunities stem from robust clinical demand, clear national policies supporting domestic manufacturing, and sustained capital investment in relevant companies. However, market expansion faces several obstacles: the exceptionally high technical barriers involve the complex integration of opto-mechatronic and fluid control systems; the lengthy product development and stringent registration approval cycles, typical for Class III medical devices, pose significant commercial challenges; furthermore, within the context of healthcare cost containment, the high cost of both the devices and their consumables also impedes rapid market penetration.
This report is a detailed and comprehensive analysis for global Phacoemulsification-Vitrectomy System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Phacoemulsification-Vitrectomy System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Phacoemulsification-Vitrectomy System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Phacoemulsification-Vitrectomy System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Phacoemulsification-Vitrectomy System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phacoemulsification-Vitrectomy System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phacoemulsification-Vitrectomy System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Bausch & Lomb, Geuder AG, Oertli Instrumente, Johnson & Johnson Vision, Carl Zeiss (DORC), OPTIKON (BVI Medical), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Phacoemulsification-Vitrectomy System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Mechanical Vitrectomy
Laser Vitrectomy
Market segment by Number of Pump
Single-Pump Type
Dual-Pump Type
Market segment by Cut Speed
20,000 CPM
12,000 CPM
7,500 CPM
Others
Market segment by Application
Hospital
Ophthalmology Clinic
Ambulatory Surgery Center
Major players covered
Alcon
Bausch & Lomb
Geuder AG
Oertli Instrumente
Johnson & Johnson Vision
Carl Zeiss (DORC)
OPTIKON (BVI Medical)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Phacoemulsification-Vitrectomy System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Phacoemulsification-Vitrectomy System, with price, sales quantity, revenue, and global market share of Phacoemulsification-Vitrectomy System from 2021 to 2026.
Chapter 3, the Phacoemulsification-Vitrectomy System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Phacoemulsification-Vitrectomy System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Phacoemulsification-Vitrectomy System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Phacoemulsification-Vitrectomy System.
Chapter 14 and 15, to describe Phacoemulsification-Vitrectomy System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Phacoemulsification-Vitrectomy System. Industry analysis & Market Report on Phacoemulsification-Vitrectomy System is a syndicated market report, published as Global Phacoemulsification-Vitrectomy System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Phacoemulsification-Vitrectomy System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.